Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On

Transaction worth based connected SEC Form 4 weighted mean acquisition terms ($14.53).

• How does this merchantability subordinate to Rubinstein's wide ownership and capableness for aboriginal sales?
  The 38,120 shares sold correspond 7.85% of her nonstop Common Stock holdings arsenic of the transaction date, with 447,202 shares remaining straight owned and further options outstanding for aboriginal conversion.

• What is the derivative discourse for this transaction?
  The merchantability progressive the workout of banal options, instantly followed by open-market sales, indicating the disposition was facilitated by conversion, not a nonstop simplification of pre-existing Common Stock.

• Does Rubinstein clasp worldly vulnerability to Adaptive Biotechnologies post-sale?
  Yes, she maintains a nonstop holding of 447,202 shares of Common Stock, providing ongoing equity information and alignment with shareholders.

* 1-year show calculated utilizing April 2nd, 2026 arsenic the notation date.

• Key products see immunoSEQ, clonoSEQ, and T-Detect COVID, with gross generated from immunosequencing research, objective diagnostics, and illness monitoring services.

• The institution operates a platform-driven model, leveraging proprietary immune medicine exertion to supply diagnostic and monitoring solutions for oncology, infectious diseases, and autoimmune conditions.

• Primary lawsuit segments see beingness sciences research, objective diagnostics, and cause find applications.

Adaptive Biotechnologies Corporation is simply a commercial-stage biotechnology institution specializing successful immune-driven diagnostics and monitoring solutions. Its strategy centers connected leveraging a proprietary immune medicine level to alteration earlier and much precise illness detection, supported by collaborations with manufacture leaders specified arsenic Genentech and Microsoft.

With a increasing portfolio of objective and probe products, Adaptive Biotechnologies delivers data-driven solutions to the healthcare and beingness sciences sectors, aiming to beforehand personalized medicine and amended diligent outcomes.